An attempt to outlaw blended radioactive waste failed during the final meeting of the Radiation Control Board.

Board members stood by the Radiation Control Division's decision to allow EnergySolutions to accept blended waste each year while it prepares a site study showing that the practice is safe, even for large volumes of the blended waste.

EnergySolutions creates blended waste by combining high-level radioactive waste that is banned in Utah with lower-level waste to make a mixture of waste acceptable for dumping in Utah.

Critics of down-blending say the spirit of Utah's law is being violated. Matt Pacenza, the policy director fo HEAL Utah, one of the biggest critics of the process, says the meeting didn't go as he had hoped.

"We're disappointed. We wish that Gov. Herbert and his administration and this board would do more to stand up to EnergySolutions and would do more to protect Utahns from hotter blended waste," said Matt Pacenza.

Utah teens stood up against tobacco at the Gateway Mall on Friday as part of the 17th annual Kick Butts Day.

Teens stood on soap boxes and raised their voices against the big tobacco companies. The goal is to stop other teens from being pressured into taking that first cigarette and becoming addicted.

The tobacco industry spends nearly $60 million every year advertising to Utahns.

"In Utah, there's 12-hundred Utahns that die every year from tobacco-related illnesses and in the US, 440-thousand Americans die so it's pretty big numbers and we want to shrink that number down as much as possible," said Gabe Giissmeyer with One Good Reason.

The teens also created a memory wall that honors friends and family who have lost their lives to tobacco.

SALT LAKE CITY (AP) -- The University of Utah College of Pharmacy is getting $24.5 million of federal money to research treatments for drug-resistant epilepsy.

School officials announced Monday that they are receiving a five-year contract with the Anticonvulsant Drug Development Program within the National Institutes of Health. The program has received the support continuously since 1974.

Epilepsy is a neurological disorder characterized by repeated seizures. More than 3 million people in the U.S. and 50 million people worldwide are affected by it.

The disease is most commonly treated with medication, but researchers say about 30 percent of people with epilepsy still have uncontrolled seizures or intolerable medication side effects.

Utah's program has participated in developing the majority of new anti-epilepsy drugs introduced to clinical use in the United States during the past 30 years.